B3GALNT2 is a UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (EC 2.4.1.313), a type II single-pass membrane glycosyltransferase of the GT31 (beta-1,3-glycosyltransferase) family. It transfers N-acetylgalactosamine (GalNAc) from UDP-GalNAc in a beta-1,3 linkage onto a terminal beta-linked N-acetylglucosamine (GlcNAc), producing the disaccharide GalNAc-beta1-3-GlcNAc. Its principal physiological role is in the elongation of the O-mannosyl glycan of alpha-dystroglycan (DAG1): acting immediately after POMGNT2 (which adds beta-1,4-GlcNAc to protein O-mannose), B3GALNT2 caps the chain with beta-1,3-GalNAc to form the core M3 trisaccharide GalNAc-beta3-GlcNAc-beta4-mannose. This trisaccharide is the obligate substrate for 6-O-phosphorylation of the mannose by POMK and for subsequent extension by FKTN, FKRP, RXYLT1, B4GAT1 and LARGE into matriglycan, the polysaccharide that mediates high-affinity binding of alpha-dystroglycan to laminin-G domain-containing extracellular matrix proteins. In addition to this O-mannosyl glycan, B3GALNT2 can synthesize the same type-I LacdiNAc (GalNAc-beta1,3-GlcNAc) disaccharide on the N-glycans of mainly intracellular glycoproteins, although the physiological significance of this broader activity is not yet established. The enzyme is broadly expressed (highest in testis, adipose, skeletal muscle and ovary) and localizes mainly to the endoplasmic reticulum and partly to the Golgi apparatus. Biallelic loss-of-function mutations cause hypoglycosylation of alpha-dystroglycan and a congenital muscular dystrophy-dystroglycanopathy (MDDGA11), ranging from Walker-Warburg syndrome to milder muscle-eye-brain phenotypes.
Definition: Catalysis of the transfer of an N-acetylgalactosaminyl residue from UDP-N-acetyl-D-galactosamine to the 3-position of the beta-1,4-linked N-acetylglucosamine of a protein O-linked mannosyl glycan, forming a beta-1,3 glycosidic bond and producing the GalNAc-beta1,3-GlcNAc-beta1,4-mannose (core M3) trisaccharide. EC 2.4.1.313.
Justification: The existing MF term GO:0008376 (acetylgalactosaminyltransferase activity) is defined as transfer of GalNAc to an oligosaccharide and is broader than the physiologically relevant reaction. There is no GO term specific to the protein-O-mannose-glycan acceptor / EC 2.4.1.313 reaction that B3GALNT2 performs in alpha-dystroglycan core M3 biosynthesis (a gap flagged by the RHEA-GO project). A child of GO:0008376 grounded on RHEA:37667 / EC 2.4.1.313 would let B3GALNT2 be annotated to its exact catalytic activity.
Parent term: acetylgalactosaminyltransferase activity
Mappings:
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0000139 Golgi membrane | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Golgi membrane is the GT31-family default location inferred phylogenetically. B3GALNT2 is a type II membrane glycosyltransferase and many family members are Golgi-resident, so this is biologically plausible. However, for the experimentally characterized alpha-dystroglycan function the enzyme is shown to act in the endoplasmic reticulum, where O-mannosylation and core M3 assembly occur. Independent glycoproteomic work (Nakane et al. 2019, PMID:30898876) concurs that B3GALNT2 "mainly localizes in the ER and partly in the Golgi apparatus", supporting the keep-as-non-core call for the Golgi membrane location. Keep as a plausible secondary location but not the core experimentally supported compartment. Supporting Evidence: PMID:30898876 B3GALNT2 mainly localizes in the ER and partly in the Golgi apparatus file:human/B3GALNT2/B3GALNT2-deep-research-falcon.md primary experimental evidence more strongly supports ER localization for active B3GALNT2 |
| GO:0006493 protein O-linked glycosylation | IBA GO_REF:0000033 | MODIFY | Summary: Correct in direction but unspecific. B3GALNT2's characterized biological role is specifically the elongation of the protein O-mannosyl (core M3) glycan of alpha-dystroglycan. The more precise child term "protein O-linked glycosylation via mannose" (GO:0035269) better captures the actual O-mannosyl pathway rather than generic O-linked (e.g. mucin-type O-GalNAc) glycosylation. Proposed replacements: protein O-linked glycosylation via mannose |
| GO:0008194 UDP-glycosyltransferase activity | IBA GO_REF:0000033 | MODIFY | Summary: Not wrong (the enzyme uses a UDP-sugar donor) but over-general. The experimentally established activity is the specific acetylgalactosaminyltransferase activity (GO:0008376, supported by IDA in PMID:23929950 and biochemical characterization in PMID:14724282). This broad parent term should be replaced by the specific activity. Proposed replacements: acetylgalactosaminyltransferase activity |
| GO:0000139 Golgi membrane | IEA GO_REF:0000044 | KEEP AS NON CORE | Summary: Electronic mapping from the UniProt subcellular-location keyword (Golgi apparatus membrane, by similarity). Same content as the IBA Golgi annotation; biologically plausible family default but secondary to the experimentally supported ER localization for the alpha-DG function. |
| GO:0005783 endoplasmic reticulum | IEA GO_REF:0000044 | ACCEPT | Summary: Electronic mapping consistent with the experimental IDA localization (PMID:23453667), where B3GALNT2 was shown to localize to the ER and disease missense variants perturb this localization. Accept. |
| GO:0009101 glycoprotein biosynthetic process | IEA GO_REF:0000120 | MODIFY | Summary: Over-general process annotation derived from the InterPro glycosyltransferase family. B3GALNT2 adds a single GalNAc residue within the alpha-dystroglycan O-mannosyl glycan; the high-level "glycoprotein biosynthetic process" adds little specificity over the more informative O-mannosylation term. Replace with the specific O-mannosylation process term (consistent with the IMP annotation to the same term). Proposed replacements: protein O-linked glycosylation via mannose |
| GO:0016020 membrane | IEA GO_REF:0000002 | MARK AS OVER ANNOTATED | Summary: Trivial location from the InterPro transmembrane signature. The protein is a type II single-pass membrane protein, so "membrane" is correct but uninformative; the specific ER/Golgi membrane terms supersede it. |
| GO:0016758 hexosyltransferase activity | IEA GO_REF:0000002 | MODIFY | Summary: Broad InterPro-derived MF term (grandparent of the specific activity). The enzyme transfers a hexosamine (GalNAc), so the more precise acetylgalactosaminyltransferase activity (GO:0008376) is the appropriate term and is experimentally supported. Proposed replacements: acetylgalactosaminyltransferase activity |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | MARK AS OVER ANNOTATED | Summary: Generic "protein binding" from a high-throughput binary interactome (Y2H) screen reporting an interaction with TMBIM1. Per curation guidelines this term is uninformative about molecular function, and there is no evidence the TMBIM1 interaction is functionally relevant to the alpha-dystroglycan glycosylation pathway. Over-annotation; not a core function. |
| GO:0006493 protein O-linked glycosylation | TAS Reactome:R-HSA-8932505 | MODIFY | Summary: Reactome traceable annotation (DAG1 core M3 glycosylations). Correct directionally; same generality issue as the IBA O-glycosylation term. The Reactome pathway is specifically about alpha-DG core M3 O-mannosyl glycan synthesis, so the more specific O-mannosylation term is preferable. Proposed replacements: protein O-linked glycosylation via mannose |
| GO:0008376 acetylgalactosaminyltransferase activity | TAS Reactome:R-HSA-8931648 | ACCEPT | Summary: Correct and specific molecular function from the Reactome reaction "B3GALNT2 transfers GalNAc to GlcNAc-Man-DAG1". This is the core catalytic activity of the enzyme. Accept (concordant with the IDA annotation). |
| GO:0005789 endoplasmic reticulum membrane | TAS Reactome:R-HSA-8931648 | ACCEPT | Summary: Reactome places the reaction at the ER membrane, consistent with the experimental ER localization (PMID:23453667) and the fact that the enzyme is a single-pass ER/Golgi membrane protein acting on the O-mannosyl glycan that is assembled in the ER. Accept; this is the precise membrane sub-location. |
| GO:0008376 acetylgalactosaminyltransferase activity | IDA PMID:23929950 SGK196 is a glycosylation-specific O-mannose kinase required... | ACCEPT | Summary: Direct experimental demonstration: recombinant B3GALNT2 transfers GalNAc from UDP-GalNAc onto the GlcNAc-beta4-Man-O-peptide produced by POMGNT2, forming GalNAc-beta3-GlcNAc-beta4-Man. This is the best-supported molecular function and the core catalytic activity. Accept. |
| GO:0006493 protein O-linked glycosylation | IDA PMID:23929950 SGK196 is a glycosylation-specific O-mannose kinase required... | MODIFY | Summary: Experimentally supported involvement in O-linked glycosylation via direct assay on the alpha-DG O-mannosyl glycan. As elsewhere, the more specific child term "protein O-linked glycosylation via mannose" (GO:0035269) more precisely reflects the demonstrated O-mannosyl (core M3) elongation. Proposed replacements: protein O-linked glycosylation via mannose |
| GO:0005783 endoplasmic reticulum | IDA PMID:23453667 Mutations in B3GALNT2 cause congenital muscular dystrophy an... | ACCEPT | Summary: Direct experimental localization: B3GALNT2 localized to the ER, and disease missense variants (e.g. G247E, V268M) perturbed this localization. This is the core, experimentally supported subcellular location for the alpha-DG function. Accept. |
| GO:0009101 glycoprotein biosynthetic process | IMP PMID:23453667 Mutations in B3GALNT2 cause congenital muscular dystrophy an... | MODIFY | Summary: Mutant-phenotype evidence (patient/zebrafish loss of function causes alpha-DG hypoglycosylation) does support a role in glycoprotein biosynthesis, so this is not incorrect. However the term is very general for a single-sugar transferase; the specific process is O-mannosyl (core M3) glycan elongation of alpha-dystroglycan. Replace with the specific O-mannosylation process term. Proposed replacements: protein O-linked glycosylation via mannose |
Loading supporting contentβ¦
Download this section (compressed HTML)Q: Besides alpha-dystroglycan, are there other physiological protein substrates that carry the GalNAc-beta3-GlcNAc-beta4-Man (core M3) structure built by B3GALNT2 in vivo?
Q: Is B3GALNT2 active in the ER, the Golgi, or both for the alpha-DG pathway, and does its compartmentalization differ from canonical Golgi GT31 family members?
Q: Does the in vitro activity toward N-glycan and core-2 O-GalNAc acceptors (reported in the original characterization) reflect any biological function, or is the O-mannosyl core M3 its sole in vivo role? Glycoproteomics (PMID:30898876) shows B3GALNT2-dependent type-I LacdiNAc on N-glycans of intracellular/ER glycoproteins (e.g. LRP1, nicastrin), but the physiological significance of these N-glycan modifications is not yet established.
Experiment: Glycoproteomic / mass-spectrometric profiling of alpha-dystroglycan and the broader glycoproteome in B3GALNT2-knockout versus wild-type cells to confirm loss of the GalNAc-beta3-GlcNAc-beta4-Man core M3 structure and to identify any additional core-M3-bearing substrates.
Experiment: In vitro reconstitution of the POMGNT2 -> B3GALNT2 -> POMK reaction sequence with defined glycopeptide acceptors to quantify B3GALNT2 kinetics on the physiological O-mannosyl acceptor and confirm strict dependence of POMK phosphorylation on prior B3GALNT2 action.
Experiment: Structure-function analysis of MDDGA11 missense variants (e.g. G247E, V268M, R292P) measuring catalytic activity, ER retention/localization, and protein stability to dissect how each impairs alpha-DG glycosylation.
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)